Predix appoints VP
Executive Summary
Stephen Donohue, MD, assumes the position of Predix VP-clinical & regulatory development. Donohue is responsible for overseeing Predix' clinical research program and will manage product submissions to FDA. Donohue previously served as a medical director overseeing atherosclerosis and metabolism clinical research at Merck, helping to guide Vytorin through the regulatory process...